| 000 | 01344 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517015141.0 | ||
| 264 | 0 | _c20151222 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1434-9949 | ||
| 024 | 7 |
_a10.1007/s10067-015-2887-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPineda, Carlos | |
| 245 | 0 | 0 |
_aRecommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view. _h[electronic resource] |
| 260 |
_bClinical rheumatology _cApr 2015 |
||
| 300 |
_a635-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBiological Products |
| 650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLatin America |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aPharmacovigilance |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aCaballero-Uribe, Carlo V | |
| 700 | 1 | _ade Oliveira, Marcia Gonclaves | |
| 700 | 1 | _aLipszyc, Pedro Saul | |
| 700 | 1 | _aLopez, Jose Julian | |
| 700 | 1 | _aMataos Moreira, Marcelo Mario | |
| 700 | 1 | _aAzevedo, Valderilio Feijo | |
| 773 | 0 |
_tClinical rheumatology _gvol. 34 _gno. 4 _gp. 635-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-015-2887-0 _zAvailable from publisher's website |
| 999 |
_c24614980 _d24614980 |
||